Why the study?
Do selective P2Y1 and P2Y12 antagonists differentially affect thrombin generation and platelet procoagulant activity in isolated platelets and platelet-rich plasma?
Population
Isolated platelets and platelet-rich plasma
Comparison
Selective P2 antagonists MRS2179 and AR-C69931MX vs Control (implied, untreated)
Design
Preclinical
Authors
Loading...
Animal data support P2Y12 selectivity in thrombosis models; leaves open human translation and clinical relevance.
Do selective P2Y1 and P2Y12 antagonists differentially affect thrombin generation and platelet procoagulant activity in isolated platelets and platelet-rich plasma?
The study demonstrates that P2Y12, but not P2Y1, is critical for thrombin-induced phosphatidylserine exposure and thrombin generation, providing mechanistic support for P2Y12 inhibitors as antithrombotic agents.
Léon et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: